Distribution and Metabolism of Salicyl-azo-sulfapyridine. I. A Study with C-14-5-amino-salicylic Acid
Overview
Authors
Affiliations
Choi J, Park M, Shin S, Byeon J, Lee B, Park Y Molecules. 2021; 26(4).
PMID: 33671835 PMC: 7926890. DOI: 10.3390/molecules26041179.
Brownfoot F, Hannan N, Cannon P, Nguyen V, Hastie R, Parry L EBioMedicine. 2019; 41:636-648.
PMID: 30824385 PMC: 6442229. DOI: 10.1016/j.ebiom.2019.02.013.
Nephrotoxic lesions from 5-aminosalicylic Acid.
Calder I, Funder C, Green C, Ham K, Tange J Br Med J. 2010; 1(5793):152-4.
PMID: 20791817 PMC: 1787127. DOI: 10.1136/bmj.1.5793.152.
Modulation of cisplatin cytotoxicity by sulphasalazine.
Awasthi S, Sharma R, SINGHAL S, Herzog N, Chaubey M, Awasthi Y Br J Cancer. 1994; 70(2):190-4.
PMID: 7914420 PMC: 2033482. DOI: 10.1038/bjc.1994.278.
The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.
Azadkhan A, TRUELOVE S, Aronson J Br J Clin Pharmacol. 1982; 13(4):523-8.
PMID: 6121576 PMC: 1402052. DOI: 10.1111/j.1365-2125.1982.tb01415.x.